AdvanDx Raises $15 Million

AdvanDx Inc., a Woburn, Mass.-based provider of in vitro molecular diagnostic products, has raised $15 million in Series C funding. BioMerieux led the deal, and was joined by return backers LD Pensions and SLS Venture. The company had previously raised $10 million. www.advandx.com